eFFECTOR Therapeutics, Inc.
EFTRDelisted Jul 19, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828522
eFFECTOR Therapeutics, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $251.1K in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding eFFECTOR Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 19 | 24 | +5 |
| Shares | 22.5M | 24.1M | +1.64M (+7.3%) |
| Value | $89.7M | $33.9M | −$55.9M (−62.3%) |
New holders (7)
Institutions that held eFFECTOR Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Evolution Capital Management LLC | 527,885 | $750.0K | 1.12% |
| Resolute Financial, LLC | 30,000 | $43.0K | 0.04% |
| Renaissance Technologies LLC | 29,288 | $42.0K | 0.00% |
| Callan Capital, LLC | 20,000 | $28.0K | 0.00% |
| Virtu Financial LLC | 15,667 | $22.0K | 0.00% |
| Advisor Group Holdings, Inc. | 1,500 | $2.00K | 0.00% |
| Simplex Trading, LLC | 141 | $0 | 0.00% |
Sold out (2)
Institutions that held eFFECTOR Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Alps Advisors Inc | 46,537 | $187.0K |
| UBS Group AG | 141 | $1.00K |